journal article·2019-01-23

From Structure to Function: pH-Switchable Antimicrobial Nano-Self-Assemblies

Mark Gontsarik, Anan Yaghmur, Qun Ren, Katharina Maniura-Weber, Stefan Salentinig

Publisher page

Abstract

Stimuli-responsive nanocarriers based on lipid self-assemblies have the potential to provide targeted delivery of antimicrobial peptides, limiting their side effects while protecting them from degradation in the biological environments. In the present study, we design and characterize a simple pH-responsive antimicrobial nanomaterial, formed through the self-assembly of oleic acid (OA) with the human cathelicidin LL-37 as a model for an amphiphilic antimicrobial peptide. Colloidal transformations from core-shell cylindrical micelles with a cross-sectional diameter of ∼5.5 nm and a length of ∼23 nm at pH 7.0 to aggregates of branched threadlike micelles at pH 5.0 were detected using synchrotron small-angle X-ray scattering, cryogenic transmission electron microscopy, and dynamic light scattering. Biological in vitro assays using an Escherichia coli bacteria strain showed high antimicrobial activity of the positively charged LL-37/OA aggregates at pH 5.0, which was not caused by the pH conditions themselves. Contrary to that, negligible antimicrobial activity was observed at pH 7.0 for the negatively charged cylindrical micelles. The nanocarrier's ability to switch its biological activity "on" and "off" in response to changes in pH could be used to focus the antimicrobial peptides' action to areas of specific pH in the body. The presented findings contribute to the fundamental understanding of lipid-peptide self-assembly and may open up a promising strategy for designing simple pH-responsive delivery systems for antimicrobial peptides.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Lipid Membrane Structure and Behavior · Polydiacetylene-based materials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory for Biointerfaces, Empa Swiss Federal Laboratories for Materials Science and Technology, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland

Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark

Funding

Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung · Novartis Stiftung?f?r?Medizinisch-Biologische Forschung

References (64)

Show source-provided references
1. 10.1038/nbt126710.1038/nbt1267 ↗
2. 10.1016/j.cub.2015.11.01710.1016/j.cub.2015.11.017 ↗
3. 10.1016/j.bbamem.2015.11.00310.1016/j.bbamem.2015.11.003 ↗
4. 10.1016/j.cis.2017.01.00510.1016/j.cis.2017.01.005 ↗
5. 10.1016/j.cis.2017.04.00610.1016/j.cis.2017.04.006 ↗
6. 10.1016/j.cis.2018.02.00210.1016/j.cis.2018.02.002 ↗
7. 10.1016/j.jconrel.2005.05.01510.1016/j.jconrel.2005.05.015 ↗
8. 10.1039/C8CP03205J10.1039/C8CP03205J ↗
9. 10.1016/j.cocis.2009.12.00310.1016/j.cocis.2009.12.003 ↗
10. 10.1021/acs.langmuir.6b0033810.1021/acs.langmuir.6b00338 ↗
11. 10.1016/j.ejpb.2018.11.00910.1016/j.ejpb.2018.11.009 ↗
12. 10.1021/la049941610.1021/la0499416 ↗
13. 10.1021/nl050678i10.1021/nl050678i ↗
14. 10.1039/b609510k10.1039/b609510k ↗
15. 10.1021/acs.jpclett.6b0162210.1021/acs.jpclett.6b01622 ↗
16. 10.1016/j.colsurfb.2017.01.00410.1016/j.colsurfb.2017.01.004 ↗
17. 10.1021/la303833s10.1021/la303833s ↗
18. 10.1016/j.cocis.2017.03.00310.1016/j.cocis.2017.03.003 ↗
19. 10.1021/ar100120v10.1021/ar100120v ↗
20. 10.1016/j.ijpharm.2017.04.08210.1016/j.ijpharm.2017.04.082 ↗
21. Ericsson B. · 1991 · 469 · 25110.1021/bk-1991-0469.ch022 ↗
22. 10.1016/0927-7757(96)03563-710.1016/0927-7757(96)03563-7 ↗
23. 10.1039/C7CS00536A10.1039/C7CS00536A ↗
24. 10.1021/la048271110.1021/la0482711 ↗
25. 10.1021/acs.langmuir.7b0307810.1021/acs.langmuir.7b03078 ↗
26. 10.1021/bm300646q10.1021/bm300646q ↗
27. 10.1016/j.jconrel.2016.02.04210.1016/j.jconrel.2016.02.042 ↗
28. 10.1021/acsomega.7b0015310.1021/acsomega.7b00153 ↗
29. 10.1016/j.colsurfb.2016.08.00310.1016/j.colsurfb.2016.08.003 ↗
30. 10.1021/la200591u10.1021/la200591u ↗
31. 10.1021/la503824z10.1021/la503824z ↗
32. 10.1039/C7BM00929A10.1039/C7BM00929A ↗
33. 10.1021/la500835e10.1021/la500835e ↗
34. 10.1021/nn300838310.1021/nn3008383 ↗
35. 10.1128/AEM.01220-0910.1128/AEM.01220-09 ↗
36. Fallingborg J. · Dan. Med. Bull. · 1999 · 46 · 183
37. 10.1023/A:101582790830910.1023/A:1015827908309 ↗
38. 10.1016/j.molmed.2016.04.00310.1016/j.molmed.2016.04.003 ↗
39. Kesselman E. · 2017 · 171
40. 10.1038/nmeth.201910.1038/nmeth.2019 ↗
41. 10.1063/1.43252810.1063/1.432528 ↗
42. 10.1107/S002188989601574910.1107/S0021889896015749 ↗
43. 10.1107/S002188989801179010.1107/S0021889898011790 ↗
44. 10.1063/1.132177010.1063/1.1321770 ↗
45. 10.1107/S002188988100887X10.1107/S002188988100887X ↗
46. 10.1107/S002188988401189410.1107/S0021889884011894 ↗
47. 10.1089/1076629015265284610.1089/10766290152652846 ↗
48. 10.1016/j.mimet.2014.08.02310.1016/j.mimet.2014.08.023 ↗
49. 10.1038/s41598-017-14206-110.1038/s41598-017-14206-1 ↗
50. 10.1074/jbc.M80553320010.1074/jbc.M805533200 ↗
51. 10.1021/la00007a02010.1021/la00007a020 ↗
52. 10.1021/acs.langmuir.6b0225710.1021/acs.langmuir.6b02257 ↗
53. 10.1021/ct100715x10.1021/ct100715x ↗
54. 10.1016/j.cis.2006.05.02710.1016/j.cis.2006.05.027 ↗
55. 10.1107/S002188988201259X10.1107/S002188988201259X ↗
56. 10.1021/la101012a10.1021/la101012a ↗
57. 10.1063/1.47196010.1063/1.471960 ↗
58. 10.1122/1.138931510.1122/1.1389315 ↗
59. 10.1021/jp044169110.1021/jp0441691 ↗
60. 10.1016/j.cocis.2010.05.00610.1016/j.cocis.2010.05.006 ↗
61. 10.1016/j.cellimm.2012.11.00910.1016/j.cellimm.2012.11.009 ↗
62. 10.1038/nri353510.1038/nri3535 ↗
63. 10.1016/j.biomaterials.2016.01.04510.1016/j.biomaterials.2016.01.045 ↗
64. 10.2741/296410.2741/2964 ↗